Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Annals of the Rheumatic Diseases|May 26, 2019
Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosisAlsya J Affandi, Tiago Carvalheiro, Andrea Ottria, et al.
Journal of Autoimmunity|May 2, 2024
Impaired LAIR-1-mediated immune control due to collagen degradation in fibrosisTiago Carvalheiro, Wioleta Marut, M Inês Pascoal Ramos, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2020
Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomesAlsya J Affandi, Joanna Grabowska, Katarzyna Olesek, et al.
Journal of Clinical Medicine|February 12, 2021
Implication of miR-126 and miR-139-5p in Plasmacytoid Dendritic Cell Dysregulation in Systemic SclerosisEleni Chouri, Maojie Wang, Maarten R Hillen, et al.
Frontiers in Immunology|August 16, 2021
CD169 Defines Activated CD14+ Monocytes With Enhanced CD8+ T Cell Activation CapacityAlsya J Affandi, Katarzyna Olesek, Joanna Grabowska, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 9, 2022
Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic SclerosisNila H Servaas, Sanne Hiddingh, Eleni Chouri, et al.
Annals of the Rheumatic Diseases|February 23, 2019
Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targetingMaarten van der Kroef, Monica Castellucci, Michal Mokry, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 31, 2017
Association of MicroRNA-618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic SclerosisMarzia Rossato, Alsya J Affandi, Soley Thordardottir, et al.
European Journal of Immunology|August 20, 2019
Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndromeMaarten van der Kroef, Lucas L van den Hoogen, Jorre S Mertens, et al.
Pageof 4